1. Home
  2. CTMX vs PKE Comparison

CTMX vs PKE Comparison

Compare CTMX & PKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • PKE
  • Stock Information
  • Founded
  • CTMX 2008
  • PKE 1954
  • Country
  • CTMX United States
  • PKE United States
  • Employees
  • CTMX N/A
  • PKE N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • PKE Military/Government/Technical
  • Sector
  • CTMX Health Care
  • PKE Industrials
  • Exchange
  • CTMX Nasdaq
  • PKE Nasdaq
  • Market Cap
  • CTMX 380.9M
  • PKE 349.7M
  • IPO Year
  • CTMX 2015
  • PKE N/A
  • Fundamental
  • Price
  • CTMX $1.91
  • PKE $17.66
  • Analyst Decision
  • CTMX Strong Buy
  • PKE
  • Analyst Count
  • CTMX 3
  • PKE 0
  • Target Price
  • CTMX $5.67
  • PKE N/A
  • AVG Volume (30 Days)
  • CTMX 3.1M
  • PKE 207.0K
  • Earning Date
  • CTMX 08-07-2025
  • PKE 07-15-2025
  • Dividend Yield
  • CTMX N/A
  • PKE 2.83%
  • EPS Growth
  • CTMX 263.20
  • PKE 4.18
  • EPS
  • CTMX 0.49
  • PKE 0.34
  • Revenue
  • CTMX $141,100,000.00
  • PKE $63,456,000.00
  • Revenue This Year
  • CTMX N/A
  • PKE N/A
  • Revenue Next Year
  • CTMX N/A
  • PKE N/A
  • P/E Ratio
  • CTMX $3.91
  • PKE $51.98
  • Revenue Growth
  • CTMX 18.01
  • PKE 16.60
  • 52 Week Low
  • CTMX $0.40
  • PKE $11.97
  • 52 Week High
  • CTMX $3.10
  • PKE $20.73
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 39.81
  • PKE 52.30
  • Support Level
  • CTMX $1.72
  • PKE $17.41
  • Resistance Level
  • CTMX $2.43
  • PKE $18.86
  • Average True Range (ATR)
  • CTMX 0.20
  • PKE 0.63
  • MACD
  • CTMX -0.06
  • PKE -0.18
  • Stochastic Oscillator
  • CTMX 26.84
  • PKE 25.33

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About PKE Park Aerospace Corp.

Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.

Share on Social Networks: